41
Views
50
CrossRef citations to date
0
Altmetric
Article

AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2

, , , , , , , , , , & show all
Pages 3086-3099 | Received 24 Jun 2016, Accepted 26 Sep 2016, Published online: 17 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alemayehu A. Gorfe & Kwang-Jin Cho. (2021) Approaches to inhibiting oncogenic K-Ras. Small GTPases 12:2, pages 96-105.
Read now

Articles from other publishers (49)

Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, Yi-Wei Kao, Chien-Ying Huang & Pao-Hsien Chu. (2023) The Association of Background Medications on Initial eGFR Change and Kidney Outcomes in Diabetic Patients Receiving SGLT2 Inhibitor. Clinical Journal of the American Society of Nephrology 18:7, pages 858-868.
Crossref
Antonio García-España & Mark R. Philips. (2023) Origin and Evolution of RAS Membrane Targeting. Oncogene 42:21, pages 1741-1750.
Crossref
Yong Zhou & John F. Hancock. (2023) RAS nanoclusters are cell surface transducers that convert extracellular stimuli to intracellular signalling. FEBS Letters 597:6, pages 892-908.
Crossref
Stefania Pieroni, Marilena Castelli, Danilo Piobbico, Simona Ferracchiato, Damiano Scopetti, Nicola Di-Iacovo, Maria Agnese Della-Fazia & Giuseppe Servillo. (2022) The Four Homeostasis Knights: In Balance upon Post-Translational Modifications. International Journal of Molecular Sciences 23:22, pages 14480.
Crossref
Xin Zhang, Luqing Pan, Ruixue Tong, Yufen Li, Lingjun Si, Yuanjing Chen, Manni Wu & Qiaoqiao Wang. (2021) Effects of crustacean hyperglycaemic hormone RNA interference on regulation of glucose metabolism in Litopenaeus vannamei after ammonia-nitrogen exposure . British Journal of Nutrition 127:6, pages 823-836.
Crossref
Mo Zhang, Gibran Ali, Satoshi Komatsu, Runzhen Zhao & Hong-Long Ji. (2022) Prkg2 regulates alveolar type 2-mediated re-alveolarization. Stem Cell Research & Therapy 13:1.
Crossref
Ana Galan-Cobo, Christine M. Stellrecht, Emrullah Yilmaz, Chao Yang, Yu Qian, Xiao Qu, Ishita Akhter, Mary L. Ayres, Youhong Fan, Pan Tong, Lixia Diao, Jie Ding, Uma Giri, Jayanthi Gudikote, Monique Nilsson, William G. Wierda, Jing Wang, Ferdinandos Skoulidis, John D. Minna, Varsha Gandhi & John V. Heymach. (2022) Enhanced Vulnerability of LKB1-Deficient NSCLC to Disruption of ATP Pools and Redox Homeostasis by 8-Cl-Ado. Molecular Cancer Research 20:2, pages 280-292.
Crossref
Karolina Pavic, Rohan Chippalkatti & Daniel Abankwa. 2022. RAS: Past, Present, and Future. RAS: Past, Present, and Future 63 99 .
Sharon L. Campbell & Mark R. Philips. (2021) Post-translational modification of RAS proteins. Current Opinion in Structural Biology 71, pages 180-192.
Crossref
Lorenz Herdeis, Daniel Gerlach, Darryl B. McConnell & Dirk Kessler. (2021) Stopping the beating heart of cancer: KRAS reviewed. Current Opinion in Structural Biology 71, pages 136-147.
Crossref
Wei Dai, Suqing Xie, Changyan Chen & Byeong Hyeok Choi. (2021) Ras sumoylation in cell signaling and transformation. Seminars in Cancer Biology 76, pages 301-309.
Crossref
Yong Zhou & John F. Hancock. (2021) Lipid Profiles of RAS Nanoclusters Regulate RAS Function. Biomolecules 11:10, pages 1439.
Crossref
Wei-hua Wang, Tao Yuan, Mei-jia Qian, Fang-jie Yan, Liu Yang, Qiao-jun He, Bo Yang, Jin-jian Lu & Hong Zhu. (2020) Post-translational modification of KRAS: potential targets for cancer therapy. Acta Pharmacologica Sinica 42:8, pages 1201-1211.
Crossref
Paul Dent, Laurence Booth, Andrew Poklepovic, Daniel Von Hoff, Jennifer Martinez, Yong Zhou & John F. Hancock. (2021) Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib. Biochemical Pharmacology 190, pages 114642.
Crossref
Yong Zhou, Alemayehu A. Gorfe & John F. Hancock. (2021) RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains. Frontiers in Molecular Biosciences 8.
Crossref
Koichi Kitamura, Koichi Hayashi, Shinsuke Ito, Yuiko Hoshina, Masahiro Sakai, Kaede Yoshino, Keita Endo, Shigeki Fujitani & Toshihiko Suzuki. (2020) Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients—the role of antidiabetic and antihypertensive medications. Hypertension Research 44:5, pages 508-517.
Crossref
Loretta László, Anita Kurilla, Tamás Takács, Gyöngyi Kudlik, Kitti Koprivanacz, László Buday & Virag Vas. (2021) Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology. Cells 10:3, pages 667.
Crossref
Rajasree Kundu, Amitava Chandra & Ankona Datta. (2021) Fluorescent Chemical Tools for Tracking Anionic Phospholipids. Israel Journal of Chemistry 61:3-4, pages 199-216.
Crossref
Rohan Chippalkatti & Daniel Abankwa. (2021) Promotion of cancer cell stemness by Ras. Biochemical Society Transactions 49:1, pages 467-476.
Crossref
Patrícia F. Lainetti, Antonio F. Leis-Filho, Priscila E. Kobayashi, Laíza S. de Camargo, Renee Laufer-Amorim, Carlos E. Fonseca-Alves & Fabiana F. Souza. (2021) Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro. Molecules 26:5, pages 1213.
Crossref
Vinay V. Nair & Alemayehu A. Gorfe. 2021. Computational Design of Membrane Proteins. Computational Design of Membrane Proteins 141 159 .
Mo ZhouLeena Kuruvilla, Xiarong ShiStephen VivianoIan M. AhearnCaroline R. AmendolaWenjuan Su, Sana BadriJames MahaffeyNicole FehrenbacherJane Skok, Joseph Schlessinger, Benjamin E. Turk, David A. Calderwood & Mark R. Philips. (2020) Scaffold association factor B (SAFB) is required for expression of prenyltransferases and RAS membrane association. Proceedings of the National Academy of Sciences 117:50, pages 31914-31922.
Crossref
Takeshi Endo. (2020) M-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras. Experimental Cell Research 397:1, pages 112342.
Crossref
Christopher B. Marshall, Fenneke KleinJan, Teklab Gebregiworgis, Ki-Young Lee, Zhenhao Fang, Ben J. Eves, Ningdi F. Liu, Geneviève M. C. Gasmi-Seabrook, Masahiro Enomoto & Mitsuhiko Ikura. (2020) NMR in integrated biophysical drug discovery for RAS: past, present, and future. Journal of Biomolecular NMR 74:10-11, pages 531-554.
Crossref
Paul Dent, Laurence Booth, Jane L. Roberts, Andrew Poklepovic & John F. Hancock. (2020) (Curcumin+sildenafil) enhances the efficacy of 5FU and anti‐PD1 therapies in vivo. Journal of Cellular Physiology 235:10, pages 6862-6874.
Crossref
Walaa E. KattanJohn F. Hancock. (2020) RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics. Biochemical Journal 477:15, pages 2893-2919.
Crossref
Christian M. Garrido, Karen M. Henkels, Kristen M. Rehl, Hong Liang, Yong Zhou, Jordan U. Gutterman & Kwang-jin Cho. (2020) Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling. Scientific Reports 10:1.
Crossref
Sarah E. Kovar, Cody Fourman, Christine Kinstedt, Brandon Williams, Christopher Morris, Kwang-jin Cho & Daniel M. Ketcha. (2020) Chalcones bearing a 3,4,5-trimethoxyphenyl motif are capable of selectively inhibiting oncogenic K-Ras signaling. Bioorganic & Medicinal Chemistry Letters 30:11, pages 127144.
Crossref
Benjamin M. M. Grant, Masahiro Enomoto, Sung-In Back, Ki-Young LeeTeklab Gebregiworgis, Noboru Ishiyama, Mitsuhiko Ikura & Christopher B. Marshall. (2020) Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety. Science Signaling 13:625.
Crossref
Wan-Long Tsai, Chien-Ning Hsu & You-Lin Tain. (2020) Whether AICAR in Pregnancy or Lactation Prevents Hypertension Programmed by High Saturated Fat Diet: A Pilot Study. Nutrients 12:2, pages 448.
Crossref
Fang-Yi Li, Zhen-Feng Zhang, Stephanie Voss, Yao-Wen Wu, Yu-Fen Zhao, Yan-Mei Li & Yong-Xiang Chen. (2020) Inhibition of K-Ras4B-plasma membrane association with a membrane microdomain-targeting peptide. Chemical Science 11:3, pages 826-832.
Crossref
Gary A. Piazza, Xi Chen, Antonio Ward, Alex Coley, Gang Zhou, Donald J. Buchsbaum, Yulia Maxuitenko & Adam B. Keeton. (2020) Targeting cGMP/PKG signaling for the treatment or prevention of colorectal cancer with novel sulindac derivatives lacking cyclooxygenase inhibitory activity. Oncology Signaling 3, pages 1-6.
Crossref
J. Matthew Rhett, Imran Khan & John P. O’Bryan. 2020. 69 146 .
Paul Dent, Laurence Booth, Andrew Poklepovic & John F. Hancock. (2019) Signaling alterations caused by drugs and autophagy. Cellular Signalling 64, pages 109416.
Crossref
Abdelkarim, Banerjee, Grudzien, Leschinsky, Abushaer & Gaponenko. (2019) The Hypervariable Region of K-Ras4B Governs Molecular Recognition and Function. International Journal of Molecular Sciences 20:22, pages 5718.
Crossref
Paul Dent, Andrew Poklepovic & Laurence Booth. (2019) Discovery of a ‘Grail-Shaped’ Drug: Ne-ratinib and the Downregulation of Mutant RAS. EMJ Oncology, pages 81-89.
Crossref
Hong Liang, Huanwen Mu, Frantz Jean-Francois, Bindu Lakshman, Suparna Sarkar-Banerjee, Yinyin Zhuang, Yongpeng Zeng, Weibo Gao, Ana Maria Zaske, Dwight V Nissley, Alemayehu A Gorfe, Wenting Zhao & Yong Zhou. (2019) Membrane curvature sensing of the lipid-anchored K-Ras small GTPase. Life Science Alliance 2:4, pages e201900343.
Crossref
Hung-En Chen, Yu-Ju Lin, I-Chun Lin, Hong-Ren Yu, Jiunn-Ming Sheen, Ching-Chou Tsai, Li-Tung Huang & You-Lin Tain. (2019) Resveratrol prevents combined prenatal NG-nitro-L-arginine-methyl ester (L-NAME) treatment plus postnatal high-fat diet induced programmed hypertension in adult rat offspring: interplay between nutrient-sensing signals, oxidative stress and gut microbiota. The Journal of Nutritional Biochemistry 70, pages 28-37.
Crossref
Paul Dent, Laurence Booth, Jane L. Roberts, Junchen Liu, Andrew Poklepovic, Alshad S. Lalani, David Tuveson, Jennifer Martinez & John F. Hancock. (2019) Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells. Oncogene 38:30, pages 5890-5904.
Crossref
Melanie P. Muller, Tao Jiang, Chang Sun, Muyun Lihan, Shashank Pant, Paween Mahinthichaichan, Anda Trifan & Emad Tajkhorshid. (2019) Characterization of Lipid–Protein Interactions and Lipid-Mediated Modulation of Membrane Protein Function through Molecular Simulation. Chemical Reviews 119:9, pages 6086-6161.
Crossref
Laurence Booth, Jane L. Roberts, Rumeesa Rais, Richard E. CutlerJr.Jr., Irmina Diala, Alshad S. Lalani, John F. Hancock, Andrew Poklepovic & Paul Dent. (2018) Neratinib augments the lethality of [regorafenib + sildenafil]. Journal of Cellular Physiology 234:4, pages 4874-4887.
Crossref
Bindu Lakshman, Simon Messing, Eva M. Schmid, Jeffrey D. Clogston, William K. Gillette, Dominic Esposito, Bailey Kessing, Daniel A. Fletcher, Dwight V. Nissley, Frank McCormick, Andrew G. Stephen & Frantz L. Jean-Francois. (2019) Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane. Journal of Biological Chemistry 294:6, pages 2193-2207.
Crossref
Taylor E. Miller, Karen M. Henkels, Mary Huddleston, Richard Salisbury, Saber M. Hussain, Atsuo T. Sasaki & Kwang-Jin Cho. (2019) Depletion of phosphatidylinositol 4-phosphate at the Golgi translocates K-Ras to mitochondria. Journal of Cell Science.
Crossref
Ian Ahearn, Mo Zhou & Mark R. Philips. (2018) Posttranslational Modifications of RAS Proteins. Cold Spring Harbor Perspectives in Medicine 8:11, pages a031484.
Crossref
Yong Zhou & John F. Hancock. (2017) Deciphering lipid codes: K‐Ras as a paradigm. Traffic 19:3, pages 157-165.
Crossref
Ruth Nussinov, Chung-Jung Tsai & Hyunbum Jang. (2018) Oncogenic Ras Isoforms Signaling Specificity at the Membrane. Cancer Research 78:3, pages 593-602.
Crossref
Si-Yu Zhang, Benjamin Sperlich, Fang-Yi Li, Samy Al-Ayoubi, Hong-Xue Chen, Yu-Fen Zhao, Yan-Mei Li, Katrin Weise, Roland Winter & Yong-Xiang Chen. (2017) Phosphorylation Weakens but Does Not Inhibit Membrane Binding and Clustering of K-Ras4B. ACS Chemical Biology 12:6, pages 1703-1710.
Crossref
Yong Zhou, Priyanka Prakash, Hong Liang, Kwang-Jin Cho, Alemayehu A. Gorfe & John F. Hancock. (2017) Lipid-Sorting Specificity Encoded in K-Ras Membrane Anchor Regulates Signal Output. Cell 168:1-2, pages 239-251.e16.
Crossref
Maryam Darabi & Anatol Kontush. (2016) Phosphatidylserine in atherosclerosis. Current Opinion in Lipidology 27:4, pages 414-420.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.